Literature DB >> 1831828

Binding of IL-1 beta to IL-1R type II at single cell level.

A Stoppacciaro1, P Bossu, P Ghiara, L P Ruco, S Censini, G Scapigliati, S Nuti, A Tagliabue, C D Baroni, D Boraschi.   

Abstract

To gain information on the possible biologic role of IL-1R type II (IL-1RII), expression of the 68-kDa IL-1 binding protein on human lymphoblastoid B cells was investigated at single cell level. Binding of iodinated IL-1 beta was evaluated by autoradiography on cytosmears of IL-1RII positive B cell lines RAJI, the RAJI clone 1H7, and STS 25. Results obtained suggest an heterogeneity of IL-1RII expression within the B cell population, with only 5 to 16% of the cells able to bind IL-1 beta. Up-regulation of IL-1RII expression by dexamethasone, evident in conventional binding assays, was achieved through both increase in the number of IL-1 binding cells (14-30%) and augmentation of receptor density on positive cells, By combining autoradiography with immunocytochemical staining, it could be shown that about 80% of IL-1RII + cells were negative for Ki67, a nuclear antigen expressed from late G1 to M phase. Cell cycle dependent expression of IL-1RII was confirmed on cells enriched in different phases of the cell cycle by counterflow centrifugal elutriation. It is thus proposed that IL-1RII is associated to the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831828

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Interleukin-1 receptor mRNA expression in activated bovine leukocytes in vitro.

Authors:  P W Yu; L A Schuler; C J Czuprynski
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

2.  Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1.

Authors:  P Bossù; U Visconti; P Ruggiero; G Macchia; M Muda; R Bertini; C Bizzarri; A Colagrande; V Sabbatini; G Maurizi
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

3.  The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor.

Authors:  F Re; M Muzio; M De Rossi; N Polentarutti; J G Giri; A Mantovani; F Colotta
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

4.  In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.

Authors:  Susanna Ricci; Giovanni Macchia; Paolo Ruggiero; Tiziana Maggi; Paola Bossù; Li Xu; Donata Medaglini; Aldo Tagliabue; Lennart Hammarström; Gianni Pozzi; Diana Boraschi
Journal:  BMC Biotechnol       Date:  2003-09-17       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.